Introduction

Emerging Research in Toxicology & Drugs

Emerging Research in Toxicology & Drugs

← Back to Series

This webinar originally occurred on April 23, 2019
Duration: 1.5 hours

Overview

Forensic science research and development plays a key role in the advancement of the practice of forensic science, as noted by the 2009 National Academies of Science report “Strengthening Forensic Sciences in the United States: A Path Forward.”

In this installment of the Emerging Research series, four researchers will present their current research in the toxicology and seized drugs disciplines. Dr. Anthony DeCaprio will present on the development and validation of a novel blood protein modification assay for retrospective detection of drug exposure. Next, we will have Amanda Mohr presenting on the retrospective identification of synthetic cannabinoids using archived high resolution mass spectrometry data. We will also have Dr. Carl Wolf presenting his research on the development of matrix matched quality control materials and sample preparation techniques for the analysis of marijuana infused products. Our final presenter will be Dr. Christopher Mulligan discussing coupling Raman spectroscopy with ambient sampling, portable mass spectrometry for on-site, high-throughput evidence confirmation.

Detailed Learning Objectives

  1. An overview of three NIJ-supported emerging research projects in toxicology and controlled substances and their progress.
  2. Potential impact of these research projects to the forensic community.
  3. Discussion of next steps and transition of this research into the forensic community.

Presenters

  • Dr. Anthony DeCaprio, F-ABFT | Associate Professor, Department of Chemistry & Biochemistry, Florida International University
  • Amanda Mohr, MS | Forensic Scientist III, Center for Forensic Science Research and Education
  • Dr. Carl Wolf | Professor, Medical College of Virginia Commonwealth University
  • Dr. Chris Mulligan | Associate Professor of Analytical Chemistry, Illinois State University

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

White Paper – Forensic Community Drug Database Conceptualization

Date February 2024 Overview The National Institute of Justice (NIJ)-in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)-convened a virtual Medicolegal Death…

Technical Note – The Use of Neutral Losses and Common Fragments Screening by QTOF in Forensic Laboratories

Date February 2024 Overview Quadrupole time-of-flight (QTOF) mass spectrometry is an advanced analytical technique that has some capabilities that make it particularly useful in screening in toxicology cases for unknown analytes. The technology combines the power of a quadrupole mass…